[Medigen Biotechnology] Announcement of important resolutions from the 115th Annual General Meeting
Medigen Biotechnology held its Annual General Meeting on May 29, 115 (2026), approving a cash dividend of 0.112 NTD per share, the election of the 10th Board of Directors, and amendments to asset management procedures.
📋 Article Processing Timeline
- 📰 Published: May 29, 2026 at 09:00
- 🔍 Collected: May 30, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:24 (34h 24m after Collected)
1. Date of AGM: 115/05/29. 2. Resolution 1: Approval of the 114th fiscal year earnings distribution, with a total cash dividend of 6,782,003 NTD, or 0.112 NTD per share. 3. Resolution 2: No amendments to the Articles of Incorporation. 4. Resolution 3: Approval of the 114th fiscal year business report and financial statements. 5. Resolution 4: Election of 7 directors for the 10th board (including 3 independent directors), term 3 years. 6. Resolution 5: Approval of amendments to asset acquisition/disposal procedures and lifting of non-compete restrictions for new directors. 7. Other: None.
FAQ
What is the dividend for Medigen Biotechnology?
0.112 NTD per share.